EXPERIENCE WITH RECOMBINANT FACTOR VIII (RECOMBINATE) IN PREVIOUSLY UNTREATED PATIENTS (PUPs) WITH SEVERE HEMOPHILIA A

EXPERIENCE WITH RECOMBINANT FACTOR VIII (RECOMBINATE) IN PREVIOUSLY UNTREATED PATIENTS (PUPs) WITH SEVERE HEMOPHILIA A

The Recombinate PUPs study was initiated in July, 1990, in order to assess the safety and efficacy of recombinant factor VIII (r-fVIII) in young children with hemophilia A and to prospectively determine the incidence of inhibitor development among r-fVIII recipients. All study subjects have severe h...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese Jouranal of Transfusion Medicine 1993, Vol.39 (2), p.462-462
Hauptverfasser: Gomperts E, Bray, G.L, Courter, S, the Recombinate Study Group
Format: Artikel
Sprache:jpn
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Recombinate PUPs study was initiated in July, 1990, in order to assess the safety and efficacy of recombinant factor VIII (r-fVIII) in young children with hemophilia A and to prospectively determine the incidence of inhibitor development among r-fVIII recipients. All study subjects have severe hemophilia A (baseline factor VIII activity:
ISSN:0546-1448